Biosynthesis technology making strong advances Two promising pipeline candidates Inclusion in the CSE25 Index InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues down the fast track with its proprietary technology for the microbial biosynthesis of cannabinoids (http://dtn.fm/OBaw0). The company recently announced it has enabled the production of all four “gateway” cannabinoids using genetically engineered microorganisms. […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.